ITL Health Group Limited, formerly ITL Limited, is engaged in manufacturing and supplying of products into the healthcare markets. The Company's principal activities are development, manufacture, distribution and sale of medical devices, and manufacture, distribution and sale of medical procedure packs. Its segments include ITL BioMedical (BioMed), MyHealthTest Pty Ltd (MHT), and Corporate and other. The BioMed segment creates and manufactures medical devices for the blood banking and blood culture testing markets. The MHT segment is a medical biotechnology company, which provides direct to consumer pathology testing.
More about the company